U.S. flag

An official website of the United States government, Department of Justice.

Controlled substances

Protecting Against Stress & Trauma: Research Lessons for Law Enforcement– Defining the Problem

October 2019
At this Research for the Real World seminar, NIJ brought together law enforcement practitioners and leading researchers in the field of stress to discuss the current research evidence and practical benefits of targeted stress-management interventions and how they can promote officer mental wellness. In addition, this gathering provided an exploration into what additional research is needed to best support officer health and wellness, potentially highlighting priority areas for future research.

International Organized Crime: Recent Developments in Policy and Research

June 2010

Since 2008, DOJ has been reviewing its policies and programs on international organized crime, with the goal of strengthening law enforcement's response to this threat. In this NIJ Conference Panel, the speakers will explore how DOJ and other U.S. government agencies are responding to it. Attendees will learn more about the Attorney General's Organized Crime Council, the International Organized Crime Intelligence and Operations Center, and the recent National Intelligence Estimate on International Organized Crime.

Seized Drugs/Controlled Substances

Controlled substances are chemicals that have a legally recognized potential for abuse. They include “street drugs” such as heroin or ecstasy and prescription drugs such as oxycodone. Detecting and identifying controlled substances is a critical step in law enforcement's fight against drug-related crime and violence.

On this page, find links to articles, awards, events, publications, and multimedia related to controlled substances and seized drugs.

Crime File: Legalization of Drugs

January 1990

1990

This Crime File video presents overview of the nature and effects of some drug legalization in Holland; followed by an examination of arguments for and against drug legalization as presented by panelists Ethan Nadelmann, assistant professor at Princeton University, and Herbert Kleber, deputy director of the Office of National Drug Control Policy.